Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models
出版年份 2016 全文链接
标题
Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 56, Issue -, Pages S99-S109
出版商
Wiley
发表日期
2016-07-07
DOI
10.1002/jcph.695
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
- (2015) HM Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
- (2015) Bruce K. Birmingham et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers
- (2015) Mette Marie Hougaard Christensen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
- (2015) Manthena V. Varma et al. PHARMACEUTICAL RESEARCH
- Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide
- (2014) Manthena V. S. Varma et al. AAPS Journal
- Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
- (2014) Rui Li et al. CLINICAL PHARMACOKINETICS
- Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
- (2014) Marco Ferrari et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling
- (2014) Sieto Bosgra et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling
- (2014) Rui Li et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine
- (2013) M. Jamei et al. CLINICAL PHARMACOKINETICS
- Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
- (2013) X Chu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
- (2013) K L R Brouwer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
- (2013) M J Zamek-Gliszczynski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond
- (2013) Hugh A Barton et al. Expert Opinion on Drug Metabolism & Toxicology
- The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese han patients with coronary heart disease
- (2013) Bao-xia He et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia
- (2013) Mona F. Shabana et al. Molecular Diagnosis & Therapy
- Response to the Comment on the Article “Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions”
- (2013) Manthena V. S. Varma et al. PHARMACEUTICAL RESEARCH
- Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
- (2013) Manthena V. S. Varma et al. PHARMACEUTICAL RESEARCH
- Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients
- (2013) Hon-Kit Lee et al. PHARMACOGENOMICS
- Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
- (2012) Kenta Yoshida et al. Annual Review of Pharmacology and Toxicology
- From preclinical to human - prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example
- (2012) Vikash Kumar Sinha et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies
- (2012) Yuan Chen et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions
- (2012) Gian Camenisch et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
- (2012) Yoshihisa Shitara et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review
- (2012) S-M Huang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transporter-Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
- (2012) K Yoshida et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
- (2012) A Rostami-Hodjegan CLINICAL PHARMACOLOGY & THERAPEUTICS
- Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions
- (2012) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals
- (2012) Qiang Fu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions
- (2012) Maria Karlgren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
- (2012) Emi Kimoto et al. MOLECULAR PHARMACEUTICS
- Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
- (2012) Manthena V. S. Varma et al. PHARMACEUTICAL RESEARCH
- Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
- (2012) Michael Gertz et al. PHARMACEUTICAL RESEARCH
- The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin
- (2011) Nicholas G. Martin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia
- (2011) Renata M. Oballa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus
- (2011) Jeffrey A. Pfefferkorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
- (2011) Maria Karlgren et al. PHARMACEUTICAL RESEARCH
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
- (2009) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
- (2009) O. A. Fahmi et al. DRUG METABOLISM AND DISPOSITION
- Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
- (2009) Agnès Poirier et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- Prediction of the Pharmacokinetics of Atorvastatin, Cerivastatin, and Indomethacin Using Kinetic Models Applied to Isolated Rat Hepatocytes
- (2008) S. W. Paine et al. DRUG METABOLISM AND DISPOSITION
- A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro
- (2008) O. A. Fahmi et al. DRUG METABOLISM AND DISPOSITION
- CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin
- (2008) Yuan Gao et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now